tiprankstipranks
Trending News
More News >
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
US Market

Citius Pharmaceuticals (CTXR) Ratios

Compare
1,778 Followers

Citius Pharmaceuticals Ratios

CTXR's free cash flow for Q1 2026 was $0.65. For the 2026 fiscal year, CTXR's free cash flow was decreased by $ and operating cash flow was $-2.29. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Dec 23Sep 22
Liquidity Ratios
Current Ratio
0.99 0.62 0.40 5.95 9.84
Quick Ratio
0.40 0.13 0.17 5.95 9.84
Cash Ratio
0.20 0.09 0.09 4.58 9.21
Solvency Ratio
-0.75 -0.70 -0.91 -2.66 -3.16
Operating Cash Flow Ratio
-0.91 -0.59 -0.79 -5.03 -6.26
Short-Term Operating Cash Flow Coverage
-34.84 -26.55 -116.75 -133.07 -143.97
Net Current Asset Value
$ -8.98M$ -25.48M$ -28.33M$ 22.19M$ 33.99M
Leverage Ratios
Debt-to-Assets Ratio
0.01 0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.02 0.03 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.02 0.03 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.01 0.00 0.00 0.00
Financial Leverage Ratio
1.76 1.94 1.66 1.14 1.11
Debt Service Coverage Ratio
-26.52 -30.97 -162.35 -148.13 -74.63
Interest Coverage Ratio
-88.60 -143.87 0.00 0.00 -132.52
Debt to Market Cap
0.11 0.13 <0.01 <0.01 <0.01
Interest Debt Per Share
0.10 0.19 0.02 0.05 0.10
Net Debt to EBITDA
0.16 0.06 0.08 0.82 1.25
Profitability Margins
Gross Profit Margin
61.41%0.00%0.00%0.00%0.00%
EBIT Margin
-948.70%0.00%0.00%0.00%0.00%
EBITDA Margin
-930.12%0.00%0.00%0.00%0.00%
Operating Profit Margin
-950.92%0.00%0.00%0.00%0.00%
Pretax Profit Margin
-958.29%0.00%0.00%0.00%0.00%
Net Profit Margin
-909.87%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
-985.09%0.00%0.00%0.00%0.00%
Net Income Per EBT
94.95%96.77%100.74%101.80%101.74%
EBT Per EBIT
100.78%100.41%92.51%87.03%99.25%
Return on Assets (ROA)
-25.56%-28.59%-33.55%-31.41%-29.51%
Return on Equity (ROE)
-52.54%-55.42%-55.85%-35.83%-32.72%
Return on Capital Employed (ROCE)
-36.70%-44.79%-51.95%-37.55%-30.43%
Return on Invested Capital (ROIC)
-36.30%-44.23%-51.64%-37.38%-30.33%
Return on Tangible Assets
-92.45%-130.02%-269.83%-93.34%-74.34%
Earnings Yield
-202.22%-272.82%-26.97%-19.52%-11.42%
Efficiency Ratios
Receivables Turnover
0.97 0.00 0.00 0.00 0.00
Payables Turnover
0.14 0.02 0.04 0.07 0.15
Inventory Turnover
0.07 <0.01 0.03 0.00 0.00
Fixed Asset Turnover
4.72 0.00 0.00 0.00 0.00
Asset Turnover
0.03 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
-0.46 0.00 0.00 0.00 0.00
Cash Conversion Cycle
3.16K 14.64K 5.82K -5.50K -2.37K
Days of Sales Outstanding
374.72 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
5.43K 37.97K 14.40K 0.00 0.00
Days of Payables Outstanding
2.64K 23.33K 8.58K 5.50K 2.37K
Operating Cycle
5.80K 37.97K 14.40K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-1.62 -2.40 -2.43 -2.98 -2.91
Free Cash Flow Per Share
-1.62 -2.40 -2.43 -2.98 -2.91
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
-19.04 -14.64 -107.28 -60.39 -41.82
Operating Cash Flow to Sales Ratio
-8.83 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-377.60%-193.52%-19.43%-17.43%-9.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.49 -0.37 -3.71 -5.12 -8.76
Price-to-Sales (P/S) Ratio
2.34 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
0.22 0.20 2.07 1.84 2.87
Price-to-Free Cash Flow (P/FCF) Ratio
-0.26 -0.52 -5.15 -5.74 -10.39
Price-to-Operating Cash Flow Ratio
-0.51 -0.52 -5.15 -5.74 -10.39
Price-to-Earnings Growth (PEG) Ratio
-0.02 <0.01 -0.52 1.55 -4.12
Price-to-Fair Value
0.22 0.20 2.07 1.84 2.87
Enterprise Value Multiple
-0.09 -0.30 -3.68 -4.43 -7.71
Enterprise Value
3.33M 11.28M 142.12M 140.68M 253.57M
EV to EBITDA
-0.09 -0.30 -3.68 -4.43 -7.71
EV to Sales
0.85 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-0.10 -0.42 -5.04 -4.84 -8.94
EV to Operating Cash Flow
-0.10 -0.42 -5.04 -4.84 -8.94
Tangible Book Value Per Share
-0.38 -2.22 -2.42 2.33 3.56
Shareholders’ Equity Per Share
3.72 6.10 6.05 9.32 10.56
Tax and Other Ratios
Effective Tax Rate
-0.03 -0.03 -0.01 -0.02 -0.02
Revenue Per Share
0.18 0.00 0.00 0.00 0.00
Net Income Per Share
-1.67 -3.38 -3.38 -3.34 -3.45
Tax Burden
0.95 0.97 1.01 1.02 1.02
Interest Burden
1.01 1.01 1.00 1.00 1.00
Research & Development to Revenue
2.19 0.00 0.00 0.00 0.00
SG&A to Revenue
4.78 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
3.19 0.00 0.00 0.00 0.00
Income Quality
0.92 0.67 0.72 0.89 0.84
Currency in USD